Current Issues in Bioavailability & Bioequivalence

The assessment of BA/BE of different drug products is based on the fundamental assumption that two products are equivalent when the rate and extent of absorption of the test drug does not show a significant difference from the rate and extent of absorption of the reference drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses. Should the rate of absorption actually differ between products, it would have to be intentional and reflected in the proposed product label and be clearly demonstrated that it is not essential in the attainment of effective body drug concentrations on chronic use or has been shown to be medically insignificant for the drug. In practice, equivalence is indicated when key pharmacokinetic parameters used to establish rate and extent of the test, and reference products fall within a preset confidence interval. The FDA declares a drug product to be therapeutically equivalent to the innovator product if it is pharmaceutically equivalent, i.e., same active ingredient, dosage form, strength and route of administration, and bioequivalent. Products that are therapeutically equivalent can be used interchangeably. Thus, BE studies are construed to be considered surrogates for comparative clinical trials for the assessment of therapeutic equivalence in safety and efficacy between two drug products.

  • Bioequivalence studies on various dose combinations
  • Bioequivalence criteria for inhaled corticosteroids
  • Enhanced oral bioavailability of hydrophobic drugs

Related Conference of Current Issues in Bioavailability & Bioequivalence

February 12-13, 2020

14th Global Pharmacovigilance and Clinical Trials Summit

Sydney, Australia
February 12-13, 2020

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, Newzealand
June 28-30 2020

Biosimilars 2020

June 28-30 2020

Bio-Similars-Meetings-2020

March 25-26, 2020

23rd Asia Pacific Pharma Congress

| Singapore
March 30-31, 2020

20th Medicinal & Pharmaceutical Sciences Congress

Osaka, Japan
April 01-02, 2020

13th European Biosimilars Congress 2020

London, UK
April 09-10, 2020

World Pharma Expo

Bangkok, Thailand
April 27-28, 2020

5th Pharmaceutical Chemistry Conference

Prague, Czech Republic
April 27-28, 2020

7th European Biopharma Congress

Prague, Czech Republic
May 06-07, 2020

15th Annual Meet on Euro Ethnopharmacology

Prague | Czech Republic
May 10-11, 2020

20th Annual Meet on Pharmaceutical Sciences

Yokohama, Japan
May 18-19, 2020

30th Annual European Pharma Congress

Berlin, Germany
May 27-28, 2020

14th World Drug Delivery Summit

| London, UK
June 28-30 2020

Automobile Engineering 2020

June 24-25, 2020

6thWorld Congress on Medicinal Plants and Marine Drugs

Amsterdam, Netherlands
June 24-25, 2020

25th International Congress on Pharmaceutical Biotechnology

Amsterdam, Netherlands
June 29-30, 2020

12th World Congress on Neuropharmacology

Athens, Greece
July 29-31, 2020

Global Pharma Summit and Expo

Shanghai, China
August 26-27, 2020

33rdWorld Congress on Pharmacology

Barcelona, Spain
September 01-02, 2020

38th Annual Midwifery Summit

Osaka, Japan
September 07-08, 2020

Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
September 10-11, 2020

World Congress on Rare Diseases & Orphan Drugs

| Prague, Czech Republic
September 14-15, 2020

Global Pharmacovigilance And Clinical Trials Summit

Shanghai, China
September 18-19, 2020

International Conference on Pharmaceutical Chemistry

Dubai, UAE
September 21-22, 2020

35th World Pharmacology and Toxicology Forum

Tokyo, Japan
September 24-25, 2020

20thWorld Congress on Advances in Pharmaceutical Sciences

Singapore, Singapore
October 05-06, 2020

International Congress on Drug Delivery

Auckland, Newzealand
October 15-16, 2020

nanomedicine-pharma-2020

Rome, Italy
October 21-22, 2020

World Summit on Drug Delivery System

Frankfurt, Germany
October 21-22, 2020

World Congress on Pharma and Clinical Trials

Frankfurt, Germany
October 26-27, 2020

22nd International Conference on Drug Design and Development

Amsterdam, Netherlands
November 09-10, 2020

2nd World Congress on Drug Discovery and Drug Design

| Tokyo, Japan
November 9-10, 2020

Annual Meet on Pharmacovigilance & Drug Safety

Tokyo, Japan
November 09-10 , 2020

Asia Pacific Pharmaceutics & Drug Delivery Congress

| Tokyo , Japan
November 11-12, 2020

4th World Congress on Eye and Vision

Dubai, UAE
November 16-17, 2020

World Congress on Biologics and Biosimilars

Kyoto, Japan
November 16-17, 2020

Pharma Expo China

Shanghai, China
November 16-17, 2020

Pharmaceutics & Novel Drug Delivery Summit China

Shanghai, China
November 23-24, 2020

21st Middle East PharmaTech & Expo

Istanbul, Turkey
November 26-27, 2020

11th World Congress on Bioavailability and Bioequivalence

Istanbul, Turkey
December 02-03, 2020

International Conference onBiotechnology and Healthcare

Auckland, Newzealand
December 02-03, 2020

2nd International Conference on Bio-Pharmaceuticals

Auckland, Newzealand

Current Issues in Bioavailability & Bioequivalence Conference Speakers

Recommended Sessions

Related Journals

Are you interested in